Clinical Trials, Research & Surveys | HSconnect

Copy%20of%20HS%20Connect%20(3)_edited.pn

Provider Portal Login

clinical trials

Clinical trials, research and surveys are open until the quota of participants is met or the study is concluded. We are consistently checking and updating this page. If you come across a study that is closed or no longer accepting participants, please let us know here.

It is the responsibility of each of us with HS to participate in whatever studies, research and surveys possible to further the research and knowledge of HS for ourselves, friends and other warriors currently suffering and those who haven't yet been diagnosed.

Attention Researchers, Physicians, Pharmaceutical Reps or Sponsors

If you are interested in listing your clinical trial, please contact us here.

"PARTICIPATE LIKE THE FUTURE OF HS DEPENDS ON IT, BECAUSE IT DOES."

Hiding in Plain Sight: Impact of Shame on Patietns with HS

Impact of Skin Health on Quality of Life Survey

Testing a Body - Functionality Intervention in Individuals with Skin Conditions

Battlefield Acupuncture for Pain

Epidermal Barrier Function with Anti-Oxidant Defense Mechanisms in Skin Conditions

Wound Etiology and Healing Study WE-HEAL

Negative Pressure Wound Therapy

LY3041658 in Adults with HS Study

Tofacitinib for Immune Skin Conditions in Down Syndrome

StuffThatWorks

Safety and Efficacy of 3 kinase inhibitors

Long-Term Safety and Effectiveness of Humira Study

Repeat Doses of CSL324 with HS and Palmoplantar Pustulosis

Observational Registry and Biospecimen Repository

Efficacy and Safety of INCB054707

TARGET-DERM - 5 Year Study for Patients Undergoing IMISC

Cutaneous and Circulating Inflammatory Biomarkers

Interdisciplinary Care Compared to Usual Care

Reconstructions w/ Back Donor Site Flaps & Validation of QOL Scales

Effect of Sclerotherapy on Fistulas and Sinus Tracts in HS

Study and Efficacy of Safety in Investigational Treatments

HS Patient Immersion Discussion Testimonial/Interview Study

Bimekizumab for Moderate to Severe HS BE HEARD I

Impact of HS on Quality of Life Functions

Bimekizumab for Moderate to Severe HS BE HEARD II

Treatment for HS with Eth 755nm Alexnadrite Laser

Investigational Treatments in Patients with Moderate to Severe HS

National Registry for Patients with HS

UCSF COVID Registry

Complement C5a Receptors in Hidradenitis Suppurativa

National Registry for Patients with HS

Wound Dressings for HS University of Miami

Ohio State University Oral Health & Modifiable Risk Factors with HS

Efficacy and Safety of Two Secukinumab Dose Regimens

FDA Clinical Trials for HS

UK Clinicial Trials for Hidradenitis Suppurativa

The purpose of the study is to test the efficacy and safety of bimekizumab in study participants with moderate to severe hidradenitis suppurativa (HS).

NCT04242498